Physician

Ajay K Thakur, M.D.

According to 2025 Medicare claims, Ajay Thakur, M.D. (NPI: 1326231994) practices nephrology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU INTERNAL MEDICINE, LLC (NPI: 1740231448; TIN: 311369596) and primary practice location at 43210-1240. Thakur is affiliated with the Rochester Regional Health ACO, Inc. (ACO ID: A3476), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Thakur's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 230 traditional Medicare patients, billed 647 HCPCS/CPT codes, and received $52,917 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,133 prescription claims across 156 beneficiaries totaling $251,061 in drug costs, led by Prevymis (Letermovir). DME data shows 1,569 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $66,489 and ending at $52,917. Concurrently, Part D prescription costs have risen steadily, from $41,501 to $251,061. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,810 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	427	1,108	$66,489
2016	265	600	$42,409
2017	284	572	$41,164
2018	167	324	$22,666
2019	N/R	N/R	N/R
2020	54	258	$24,167
2021	105	238	$23,703
2022	55	83	$8,932
2023	247	650	$63,167
2024	230	647	$52,917

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	157	461	$41,501
2016	32	88	$3,328
2017	40	86	$11,669
2018	36	79	$2,677
2019	18	93	$1,859
2020	29	130	$8,901
2021	22	204	$36,450
2022	12	68	$6,900
2023	110	719	$197,172
2024	156	1,133	$251,061

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	21	$2,698
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	20	$256
2021	22	197	$14,318
2022	N/R	72	$2,015
2023	120	676	$20,490
2024	255	1,569	$46,501

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	34	36	$123
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	68	95	$96
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	74	222	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	61	91	$61
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	36	52	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prevymis	Letermovir	20	560	$139,969
Atovaquone	Atovaquone	20	720	$13,843
Lokelma	Sodium Zirconium Cyclosilicate	14	420	$13,631
Veltassa	Patiromer Calcium Sorbitex	12	360	$10,796
Valganciclovir Hcl	Valganciclovir Hcl	30	961	$6,764

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	61	374	$11,189
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	12	$7,444
J7515	Cyclosporine, oral, 25 mg	N	N/R	47	$6,627
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	68	345	$6,238
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	72	429	$5,244

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Ajay K. Thakur, M.D.?

Tedicare shows public-source Medicare data for Ajay K. Thakur, M.D. (NPI 1326231994), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajay K. Thakur, M.D. have ACO affiliation data?

Ajay K. Thakur, M.D. is shown with ACO affiliation data for Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Ajay K. Thakur, M.D.?

Ajay K. Thakur, M.D. is linked to OSU INTERNAL MEDICINE, LLC (billing NPI 1740231448) in the available physician profile data.

Does Ajay K. Thakur, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.